LINC00673 rs11655237 C>T Polymorphism Impacts Hepatoblastoma Susceptibility in Chinese Children

Abstract

Background Hepatoblastoma (HB) is the most common hepatic malignancy in children, accounting for approximately 80% of all childhood liver tumors. Previous genome-wide association studies (GWASs) have found that the LINC00673 rs11655237 C>T polymorphism is associated with the risk of several different adult cancers. However, the association between this polymorphism and HB susceptibility remains unclear. Methods We analyzed the association between the LINC00673 rs11655237 C>T polymorphism and HB susceptibility in a hospital-based study of Chinese children. We enrolled 213 HB patients and 958 healthy controls with genotypes determined by TaqMan, and the strength of the association of interest was determined by calculating odds ratios (ORs) and 95% confidence intervals (CIs). Findings We found a significant association between the LINC00673 rs11655237 C>T polymorphism and HB risk (CT/TT compared with CC: adjusted OR = 1.40, 95% CI = 1.04–1.88, p = 0.029). Furthermore, stratified analysis indicated that rs11655237 T allele carriers in the following subgroups were more likely to develop HB: children older than 17 months, males, and those with tumors of clinical stages III + IV. Interpretation In conclusion, we confirmed that the LINC00673 rs11655237 C>T polymorphism may be associated with HB susceptibility. Prospective studies with larger sample sizes and patients of different ethnicities are needed to validate our findings.

YTHDC1 gene polymorphisms and hepatoblastoma susceptibility in Chinese children: A seven‐center case–control study

“…Pakakasama et al 16 demonstrated that the CCND1 rs9344 G>A polymorphism at codon 242 may contribute to tumor development in children with hepatoblastoma. Yang et al 17 confirmed that the LINC00673 rs11655237 C>T polymorphism may be a promoting factor of hepatoblastoma susceptibility.…”

WTAP Gene Variants Confer Hepatoblastoma Susceptibility: A Seven-Center Case-Control Study

“…The selection of subjects and collection of specimens have been described previously. 22 The current study included 313 cases and 1,446 controls, enrolled from seven hospitals in China (Guangzhou, Xi’an, Zhengzhou, Changsha, Kunming, Shenyang, and Taiyuan). The patients were all newly diagnosed and pathologically confirmed with hepatoblastoma but without preoperative treatment.…”

Association between lncRNA‐H19 polymorphisms and hepatoblastoma risk in an ethic Chinese population

“…Total genomic DNA was isolated from the peripheral blood leucocytes of each patient using a TIANamp Blood DNA Kit (TianGen Biotech Co., Ltd.). H19 gene SNPs were genotyped by TaqMan real‐time PCR, 26‐28 with eight blank wells in each 384‐well plate containing water as negative controls. We also randomly repeated the genotyping of 10% of the samples, achieving a 100% concordance rate.…”